What's Happening?
David C. Hohn, who served as president and CEO of Roswell Park Comprehensive Cancer Center from 1997 to 2007, passed away on October 30 at the age of 84. Dr. Hohn is credited with revitalizing Roswell Park during a critical period when its national standing
was at risk. He initiated an aggressive campaign to modernize facilities, strengthen financial stability, reorganize research and patient care programs, and recruit leading physicians and researchers. His leadership transformed the institution from a New York State Department of Health division into an independent public benefit corporation in 1999, restoring its financial health. Dr. Hohn also played a key role in recruiting current Roswell Park President and CEO Candace S. Johnson in 2002.
Why It's Important?
Dr. Hohn's tenure at Roswell Park was pivotal in securing the institution's future as a leading cancer center. His strategic vision and decisive actions not only saved the center from potential decline but also propelled it into a period of significant growth and national recognition. By recruiting top talent, investing in infrastructure, and streamlining scientific programs, he established a foundation for advanced cancer research and patient care. His emphasis on collaboration also fostered stronger ties within the Buffalo Niagara Medical Campus and the broader region, contributing to both scientific advancement and economic development. His legacy includes the recruitment of key leaders, such as Dr. Candace S. Johnson, who have continued to build upon his foundational work, ensuring Roswell Park's ongoing impact on cancer treatment and research.
Beyond the Headlines
Dr. Hohn's impact extended beyond administrative and scientific achievements; he cultivated a culture of philanthropy and collaboration that continues to benefit Roswell Park. His personal generosity, alongside his wife Lucinda, set an example that inspired countless others to contribute to the center's mission. His understanding of the importance of reputation, as he noted in a 2003 interview, highlights a strategic approach to institutional leadership that recognized the interconnectedness of quality care, research excellence, recruitment, and donor support. Even after his retirement, Dr. Hohn remained engaged, contributing to the planning and launch of a cellular therapies manufacturing facility, demonstrating a lifelong commitment to advancing cancer treatment. His leadership serves as a model for transforming and sustaining complex medical institutions.
